Judge Refuses To Nix Bristol-Myers' Sustiva Case
By Erin Coe ( January 15, 2010, 2:42 PM EST) -- A federal judge has shot down a bid by Mylan Pharmaceuticals Inc. and Matrix Laboratories Ltd. to throw out Bristol-Myers Squibb Co.'s suit alleging the companies have infringed its patent by seeking to gain federal approval of a generic version of HIV treatment Sustiva....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.